Loading...
XASX
CLV
Market cap118mUSD
Oct 09, Last price  
1.00AUD
1D
-1.96%
1Q
32.45%
Jan 2017
92.31%
Name

Clover Corporation Ltd

Chart & performance

D1W1MN
XASX:CLV chart
P/E
15.97
P/S
1.71
EPS
0.06
Div yield, %
2.70%
Shrs. gr., 5y
0.07%
Rev. gr., 5y
9.99%
Revenues
97m
+13.26%
16,650,00021,697,00021,121,00034,937,00032,895,00038,387,00044,098,00027,190,00029,921,00042,920,00047,864,00062,961,00076,682,00088,281,00060,505,00070,660,00079,875,00062,207,00086,004,00097,410,000
Net income
10m
+49.08%
635,0004,135,0003,082,000-967,0004,249,0004,371,0006,078,000967,000100,0002,213,0003,639,0007,588,00010,101,00012,487,0006,004,0007,133,0006,205,0001,515,0007,015,00010,458,000
CFO
4m
-46.99%
772,000385,0003,409,000410,0004,813,0007,678,0002,526,0003,198,0003,106,000-63,000-595,0004,081,0004,791,0006,661,0008,228,0005,934,0006,736,0008,454,0008,287,0004,393,000
Dividend
Oct 20, 20260.0125 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Clover Corporation Limited engages in the processing and worldwide sale of natural oils, reaching markets across Australia, New Zealand, Asia, Europe, and the Americas. The company's operations also encompass the creation of encapsulated products and extensive research and development focused on functional food and infant nutrition ingredients. Among its principal offerings are Nu-Mega Hi docosahexaenoic tuna oils, designed for use in infant formula and pharmaceutical goods, alongside its Ocean Gold refined tuna oils. Furthermore, it supplies Nu-Mega Driphorm powders, which are incorporated into various infant formulas, follow-on formulas, growing-up milks, and general food products, as well as Nu-Mega Driphorm HA for non-dairy applications. These products cater to several segments, including active living (for immune and sports support), healthy living (benefiting brain and heart health), and the foundational stages of infant and child development. The company, founded in 1988, maintains its corporate headquarters in Altona North, Australia.

Key people

Non-Executive Chairman of the Board · since 2017
Peter Davey
Chief Executive Officer, Managing Director, Executive Director · since 2014
Andrew Allibon
Chief Financial Officer, Company Secretary · since 2021
Non-Executive Director · since 2025
Toni Brendish
Non-Executive Independent Director · since 2020
Ian Glasson
Non-Executive Independent Director · since 2017
Simon Green
Non-Executive Independent Director · since 2020
IPO date
Nov 30, 1999
Employees
48
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑072025‑072024‑072023‑072022‑072021‑072020‑072019‑072018‑072017‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT